Please log in to view this page
Username
Password
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
